Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JUERGENS

Showing results (391-400 of 662) with videos related to

Pageof 67
Sort By:
Clinical and Experimental Immunology|December 23, 2017
No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipientsS Bigenzahn, B Juergens, B Mahr, et al.
Plos One|October 26, 2021
Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary interventionAmir Faour, Nicholas Collins, Trent Williams, et al.
Heart, Lung & Circulation|December 15, 2005
Adverse reactions of low osmolar non-ionic and ionic contrast media when used together or separately during percutaneous coronary interventionCraig P Juergens, Aye Mi Khaing, Geraldine J McIntyre, et al.
Heart, Lung & Circulation|February 16, 2024
Robotic Assisted Percutaneous Coronary Intervention: Initial Australian ExperienceJames Leung, John French, James Xu, et al.
Cancer Treatment Reviews|February 14, 2017
Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neckRosalyn A Juergens, Scott V Bratman, Ming-Sound Tsao, et al.
European Journal of Pediatrics|August 1, 1996
Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood--follow up after 9 years. Coall Study GroupG E Janka-Schaub, D Harms, U Goebel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2021
Protein sequence design by conformational landscape optimizationChristoffer Norn, Basile I M Wicky, David Juergens, et al.
Acta Oncologica (Stockholm, Sweden)|April 18, 2022
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic diseaseSherif Ramadan, Kimmen Quan, Kara Schnarr, et al.
Plos One|November 9, 2023
Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical historyMichael Bonert, Alison Berzins, Housne Begum, et al.
Lung Cancer (Amsterdam, Netherlands)|May 13, 2026
Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian expertsJenny J Ko, Normand Blais, Anthony Brade, et al.
Pageof 67

Showing results (391-400 of 662) with videos related to

Sort By:
Pageof 67
Clinical and Experimental Immunology|December 23, 2017
No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipientsS Bigenzahn, B Juergens, B Mahr, et al.
Plos One|October 26, 2021
Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary interventionAmir Faour, Nicholas Collins, Trent Williams, et al.
Heart, Lung & Circulation|December 15, 2005
Adverse reactions of low osmolar non-ionic and ionic contrast media when used together or separately during percutaneous coronary interventionCraig P Juergens, Aye Mi Khaing, Geraldine J McIntyre, et al.
Heart, Lung & Circulation|February 16, 2024
Robotic Assisted Percutaneous Coronary Intervention: Initial Australian ExperienceJames Leung, John French, James Xu, et al.
Cancer Treatment Reviews|February 14, 2017
Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neckRosalyn A Juergens, Scott V Bratman, Ming-Sound Tsao, et al.
European Journal of Pediatrics|August 1, 1996
Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood--follow up after 9 years. Coall Study GroupG E Janka-Schaub, D Harms, U Goebel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2021
Protein sequence design by conformational landscape optimizationChristoffer Norn, Basile I M Wicky, David Juergens, et al.
Acta Oncologica (Stockholm, Sweden)|April 18, 2022
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic diseaseSherif Ramadan, Kimmen Quan, Kara Schnarr, et al.
Plos One|November 9, 2023
Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical historyMichael Bonert, Alison Berzins, Housne Begum, et al.
Lung Cancer (Amsterdam, Netherlands)|May 13, 2026
Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian expertsJenny J Ko, Normand Blais, Anthony Brade, et al.
Pageof 67